Form EFFECT Niagen Bioscience, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 9, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Niagen Bioscience (NAGE)
- Omneky Launches Public API and MCP Server, Bringing Autonomous Ad Creative Generation to Any Platform or AI Agent
- Mirion Supports Advanced Reactor Criticality Milestones Through U.S. DOE Reactor Pilot Program
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
